Article Details

Biotech firm touts new AI lung disease drug discovery amid third Hong Kong IPO attempt

Retrieved on: 2025-06-04 10:04:45

Tags for this article:

Click the tags to see associated articles and topics

Biotech firm touts new AI lung disease drug discovery amid third Hong Kong IPO attempt. View article details on hiswai:

Excerpt

Insilico Medicine said results of a clinical trial in China showed positive results in treating idiopathic pulmonary fibrosis.

Article found on: www.scmp.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo